Physician profile
Dawn E Ammon
NPI 1831310580
$592.81
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $399 · 2022: $42.03 · 2023: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $129.43 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $123.42 | 2023 | Sotyktu |
| Janssen Biotech, INC. | $77.93 | 2021 | |
| Vyne Pharmaceuticals INC. | $50.63 | 2021 | |
| Dermira, INC. | $35.88 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.72 | 2021 | |
| Lilly USA, LLC | $28.52 | 2021 | |
| Sun Pharmaceutical Industries INC. | $21.98 | 2021 | |
| Almirall LLC | $21.40 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $20.32 | 2021 | |
| Genzyme Corporation | $20.31 | 2021 | |
| Galderma Laboratories, L.P. | $15.31 | 2023 | |
| Amgen INC. | $12.96 | 2023 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Ammon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.